hepatitis C

A comprehensive package of prevention, screening, and treatment interventions could avert 15.1 million new hepatitis C infections and 1.5 million cirrhosis and liver cancer deaths globally by 2030 – equal to an 80% reduction in incidence...

New research presented at this year’s International Liver Congress in Paris, France (11-15 April) shows that while several European countries are now on target to meet WHO’s 2030 hepatitis C elimination goals, many others are off...

News Hour: No developing countries have so far come forward to buy massively discounted hepatitis C drugs to treat their populations. The Global Procurement Fund, created this year to provide discounted medications by the Center for...

News Hour: AbbVie Inc said on Friday it had received European approval to market its drug for treatment of all six major forms of hepatitis C. The company said the approval of Maviret was supported by...

News Hour: Prices of drugs to cure hepatitis C and to treat hepatitis B are dropping dramatically, offering affordability and hope to 325 million people living with the viral liver disease that can be fatal, the...

News Hour: The number of hepatitis C infections have nearly tripled in the United States in the last five years, particularly among people in their 20s, researchers said on Thursday. The bloodborne virus is transmitted by...